Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Insmed (INSM – Research Report) yesterday and set a price target ...
Insmed sees growth with ARIKAYCE and upcoming Brensocatib approval. Find out why INSM stock is a strong pick with significant ...
NOVEMBER 19, 2024 — UTSA faculty are leveraging their expertise to fight Mycobacterium tuberculosis (Mtb), the germ ...
During the 1990s, medicinal chemist Anders Hallberg was working in his lab at the Department of Medicinal Chemistry. He was exploring a hormonal system in the body that regulates blood pressure, among ...
Dietary zinc deficiency promotes lung infection by Acinetobacter baumannii bacteria—a leading cause of ventilator-associated ...
USA-based Paratek Pharmaceuticals has released positive top-line data from a Phase IIb trial evaluating its oral antibiotic ...
In a study of 66 adult patients with nontuberculous mycobacteria pulmonary disease (NTM-PD) caused by mycobacterium abscessus ...
Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses.
A fourth of patients with Mycobacterium avium complex pulmonary disease (MAC-PD) whose pre- and on-treatment isolates were the same species had genetically distinct strains within the same species in ...
A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...
Updated NTM pulmonary disease estimates in U.S. Medicare beneficiaries revealed rising incidence, demographic disparities, and associated comorbidities.